Targeting Wnt/β-Catenin Signaling Exacerbates Ferroptosis and Increases the Efficacy of Melanoma Immunotherapy via the Regulation of MITF

Melanoma is the most lethal form of skin cancer, resulting from the malignant transformation of epidermal melanocytes. Recent revolutionary progress in targeted therapy and immunotherapy has prominently improved the treatment outcome, but the survival of melanoma patients remains suboptimal. Ferropt...

Full description

Bibliographic Details
Main Authors: Hao Wang, Hengxiang Zhang, Yuhan Chen, Huina Wang, Yangzi Tian, Xiuli Yi, Qiong Shi, Tao Zhao, Baolu Zhang, Tianwen Gao, Sen Guo, Chunying Li, Weinan Guo
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/11/22/3580
_version_ 1797465660874293248
author Hao Wang
Hengxiang Zhang
Yuhan Chen
Huina Wang
Yangzi Tian
Xiuli Yi
Qiong Shi
Tao Zhao
Baolu Zhang
Tianwen Gao
Sen Guo
Chunying Li
Weinan Guo
author_facet Hao Wang
Hengxiang Zhang
Yuhan Chen
Huina Wang
Yangzi Tian
Xiuli Yi
Qiong Shi
Tao Zhao
Baolu Zhang
Tianwen Gao
Sen Guo
Chunying Li
Weinan Guo
author_sort Hao Wang
collection DOAJ
description Melanoma is the most lethal form of skin cancer, resulting from the malignant transformation of epidermal melanocytes. Recent revolutionary progress in targeted therapy and immunotherapy has prominently improved the treatment outcome, but the survival of melanoma patients remains suboptimal. Ferroptosis is greatly involved in cancer pathogenesis and can execute the outcome of immunotherapy. However, the detailed regulatory mechanisms of melanoma cell ferroptosis remain elusive. Herein, we report that Wnt/β-catenin signaling regulates ferroptosis and melanoma immunotherapy efficacy via the regulation of MITF. First of all, we found that Wnt/β-catenin signaling was prominently suppressed in melanoma cell ferroptosis. Then, we proved that targeting β-catenin exacerbated melanoma cell ferroptosis by promoting the generation of lipid peroxidation both in vitro and in vivo. Subsequent mechanistic studies revealed that MITF mediated the effect of Wnt/β-catenin signaling on melanoma cell ferroptosis, and PGC1α and SCD1 were documented as two main effectors downstream of Wnt/β-catenin-MITF pathway. Ultimately, pharmacological inhibition of β-catenin or MITF increased the efficacy of anti-PD-1 immunotherapy in preclinical xenograft tumor model by promoting ferroptosis. Taken together, Wnt/β-catenin signaling deficiency exacerbates ferroptosis in melanoma via the regulation of MITF. Targeting Wnt/β-catenin-MITF pathway could be a promising strategy to potentiate ferroptosis and increase the efficacy of anti-PD-1 immunotherapy.
first_indexed 2024-03-09T18:25:37Z
format Article
id doaj.art-ab145caa37604c80ad4ba7f7fd840534
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-09T18:25:37Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-ab145caa37604c80ad4ba7f7fd8405342023-11-24T07:57:44ZengMDPI AGCells2073-44092022-11-011122358010.3390/cells11223580Targeting Wnt/β-Catenin Signaling Exacerbates Ferroptosis and Increases the Efficacy of Melanoma Immunotherapy via the Regulation of MITFHao Wang0Hengxiang Zhang1Yuhan Chen2Huina Wang3Yangzi Tian4Xiuli Yi5Qiong Shi6Tao Zhao7Baolu Zhang8Tianwen Gao9Sen Guo10Chunying Li11Weinan Guo12Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, ChinaDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, ChinaDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, ChinaDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, ChinaDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, ChinaDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, ChinaDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, ChinaDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, ChinaDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, ChinaDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, ChinaDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, ChinaDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, ChinaDepartment of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, ChinaMelanoma is the most lethal form of skin cancer, resulting from the malignant transformation of epidermal melanocytes. Recent revolutionary progress in targeted therapy and immunotherapy has prominently improved the treatment outcome, but the survival of melanoma patients remains suboptimal. Ferroptosis is greatly involved in cancer pathogenesis and can execute the outcome of immunotherapy. However, the detailed regulatory mechanisms of melanoma cell ferroptosis remain elusive. Herein, we report that Wnt/β-catenin signaling regulates ferroptosis and melanoma immunotherapy efficacy via the regulation of MITF. First of all, we found that Wnt/β-catenin signaling was prominently suppressed in melanoma cell ferroptosis. Then, we proved that targeting β-catenin exacerbated melanoma cell ferroptosis by promoting the generation of lipid peroxidation both in vitro and in vivo. Subsequent mechanistic studies revealed that MITF mediated the effect of Wnt/β-catenin signaling on melanoma cell ferroptosis, and PGC1α and SCD1 were documented as two main effectors downstream of Wnt/β-catenin-MITF pathway. Ultimately, pharmacological inhibition of β-catenin or MITF increased the efficacy of anti-PD-1 immunotherapy in preclinical xenograft tumor model by promoting ferroptosis. Taken together, Wnt/β-catenin signaling deficiency exacerbates ferroptosis in melanoma via the regulation of MITF. Targeting Wnt/β-catenin-MITF pathway could be a promising strategy to potentiate ferroptosis and increase the efficacy of anti-PD-1 immunotherapy.https://www.mdpi.com/2073-4409/11/22/3580Wnt/β-cateninMITFferroptosismelanomaanti-PD-1 immunotherapy
spellingShingle Hao Wang
Hengxiang Zhang
Yuhan Chen
Huina Wang
Yangzi Tian
Xiuli Yi
Qiong Shi
Tao Zhao
Baolu Zhang
Tianwen Gao
Sen Guo
Chunying Li
Weinan Guo
Targeting Wnt/β-Catenin Signaling Exacerbates Ferroptosis and Increases the Efficacy of Melanoma Immunotherapy via the Regulation of MITF
Cells
Wnt/β-catenin
MITF
ferroptosis
melanoma
anti-PD-1 immunotherapy
title Targeting Wnt/β-Catenin Signaling Exacerbates Ferroptosis and Increases the Efficacy of Melanoma Immunotherapy via the Regulation of MITF
title_full Targeting Wnt/β-Catenin Signaling Exacerbates Ferroptosis and Increases the Efficacy of Melanoma Immunotherapy via the Regulation of MITF
title_fullStr Targeting Wnt/β-Catenin Signaling Exacerbates Ferroptosis and Increases the Efficacy of Melanoma Immunotherapy via the Regulation of MITF
title_full_unstemmed Targeting Wnt/β-Catenin Signaling Exacerbates Ferroptosis and Increases the Efficacy of Melanoma Immunotherapy via the Regulation of MITF
title_short Targeting Wnt/β-Catenin Signaling Exacerbates Ferroptosis and Increases the Efficacy of Melanoma Immunotherapy via the Regulation of MITF
title_sort targeting wnt β catenin signaling exacerbates ferroptosis and increases the efficacy of melanoma immunotherapy via the regulation of mitf
topic Wnt/β-catenin
MITF
ferroptosis
melanoma
anti-PD-1 immunotherapy
url https://www.mdpi.com/2073-4409/11/22/3580
work_keys_str_mv AT haowang targetingwntbcateninsignalingexacerbatesferroptosisandincreasestheefficacyofmelanomaimmunotherapyviatheregulationofmitf
AT hengxiangzhang targetingwntbcateninsignalingexacerbatesferroptosisandincreasestheefficacyofmelanomaimmunotherapyviatheregulationofmitf
AT yuhanchen targetingwntbcateninsignalingexacerbatesferroptosisandincreasestheefficacyofmelanomaimmunotherapyviatheregulationofmitf
AT huinawang targetingwntbcateninsignalingexacerbatesferroptosisandincreasestheefficacyofmelanomaimmunotherapyviatheregulationofmitf
AT yangzitian targetingwntbcateninsignalingexacerbatesferroptosisandincreasestheefficacyofmelanomaimmunotherapyviatheregulationofmitf
AT xiuliyi targetingwntbcateninsignalingexacerbatesferroptosisandincreasestheefficacyofmelanomaimmunotherapyviatheregulationofmitf
AT qiongshi targetingwntbcateninsignalingexacerbatesferroptosisandincreasestheefficacyofmelanomaimmunotherapyviatheregulationofmitf
AT taozhao targetingwntbcateninsignalingexacerbatesferroptosisandincreasestheefficacyofmelanomaimmunotherapyviatheregulationofmitf
AT baoluzhang targetingwntbcateninsignalingexacerbatesferroptosisandincreasestheefficacyofmelanomaimmunotherapyviatheregulationofmitf
AT tianwengao targetingwntbcateninsignalingexacerbatesferroptosisandincreasestheefficacyofmelanomaimmunotherapyviatheregulationofmitf
AT senguo targetingwntbcateninsignalingexacerbatesferroptosisandincreasestheefficacyofmelanomaimmunotherapyviatheregulationofmitf
AT chunyingli targetingwntbcateninsignalingexacerbatesferroptosisandincreasestheefficacyofmelanomaimmunotherapyviatheregulationofmitf
AT weinanguo targetingwntbcateninsignalingexacerbatesferroptosisandincreasestheefficacyofmelanomaimmunotherapyviatheregulationofmitf